These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29235050)

  • 1. Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.
    Canivell S; Mohaupt M; Ackermann D; Pruijm M; Guessous I; Ehret G; Escher G; Pechère-Bertschi A; Vogt B; Devuyst O; Burnier M; Martin PY; Ponte B; Bochud M
    J Endocrinol Invest; 2018 Jul; 41(7):799-808. PubMed ID: 29235050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma copeptin, a unifying factor behind the metabolic syndrome.
    Enhörning S; Struck J; Wirfält E; Hedblad B; Morgenthaler NG; Melander O
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1065-72. PubMed ID: 21490073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
    Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
    Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental 11β-HSD2 and Cardiometabolic Health Indicators in Infancy.
    Chen L; Guilmette J; Luo ZC; Cloutier A; Wang WJ; Yang MN; Fraser WD; Dubois J; Nuyt AM
    Diabetes Care; 2019 May; 42(5):964-971. PubMed ID: 30833369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between 11β-HSD2 mRNA and insulin sensitivity in term small-for-gestational age neonates after birth.
    Zhu Z; Liu Q
    Int J Clin Exp Pathol; 2015; 8(1):928-32. PubMed ID: 25755797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
    Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is copeptin a new potential biomarker of insulin resistance in polycystic ovary syndrome?
    Widecka J; Ozegowska K; Banaszewska B; Kazienko A; Safranow K; Branecka-Wozniak D; Pawelczyk L; Kurzawa R
    Ginekol Pol; 2019; 90(3):115-121. PubMed ID: 30949999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of water loading on the urinary ratio of cortisone to cortisol in healthy subjects and a new approach to the evaluation of the ratio as an index for in vivo human 11β-hydroxysteroid dehydrogenase 2 activity.
    Yokokawa A; Takasaka T; Shibasaki H; Kasuya Y; Kawashima S; Yamada A; Furuta T
    Steroids; 2012 Oct; 77(12):1291-7. PubMed ID: 22850318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
    Abdallah BM; Beck-Nielsen H; Gaster M
    Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of copeptin, a surrogate marker for arginine vasopressin secretion, with insulin resistance: Influence of adolescence and psychological stress.
    Thomsen CF; Dreier R; Goharian TS; Goetze JP; Andersen LB; Faber J; Ried-Larsen M; Grøntved A; Jeppesen JL
    Peptides; 2019 May; 115():8-14. PubMed ID: 30779927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants.
    Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Andersson S
    Pediatr Res; 2006 Apr; 59(4 Pt 1):575-8. PubMed ID: 16549532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased copeptin levels in metabolic syndrome from a Romanian population.
    Vintilă M; Gheorghiu ML; Caragheorgheopol A; Baculescu N; Lichiardopol C; Badiu C; Coculescu M; Grigorescu F; Poiană C
    J Med Life; 2016; 9(4):353-357. PubMed ID: 27928437
    [No Abstract]   [Full Text] [Related]  

  • 16. Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men.
    Wannamethee SG; Welsh P; Papacosta O; Lennon L; Whincup PH; Sattar N
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3332-9. PubMed ID: 26158609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community.
    Roussel R; El Boustany R; Bouby N; Potier L; Fumeron F; Mohammedi K; Balkau B; Tichet J; Bankir L; Marre M; Velho G
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2432-9. PubMed ID: 27049477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.
    Saleem U; Khaleghi M; Morgenthaler NG; Bergmann A; Struck J; Mosley TH; Kullo IJ
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2558-64. PubMed ID: 19366852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.